JPH06502406A - 脳中への細胞の移植方法およびそのための治療的使用 - Google Patents
脳中への細胞の移植方法およびそのための治療的使用Info
- Publication number
- JPH06502406A JPH06502406A JP3518066A JP51806691A JPH06502406A JP H06502406 A JPH06502406 A JP H06502406A JP 3518066 A JP3518066 A JP 3518066A JP 51806691 A JP51806691 A JP 51806691A JP H06502406 A JPH06502406 A JP H06502406A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- brain
- disease
- cell
- support matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0613—Cells from endocrine organs
- C12N5/0614—Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/10—Mineral substrates
- C12N2533/12—Glass
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
Abstract
Description
Claims (13)
- 1.細胞を支持体マトリックスの外側表面にインビトロで付着させ、付着した細 胞を有する支持体マトリックスを脳中に移植することからなる、哺乳類被験者の 脳中へ細胞を移植する方法。
- 2.支持体マトリックスがマイクロビーズである、請求項1記載の方法。
- 3.マイクロビーズが約90から約150μmまでの直径を有する、請求項2記 載の方法。
- 4.支持体マトリックスが酸化ケイ素、ポリスチレン、ポリプロピレン、ポリエ チレン、ポリカーボネート、ポリペンテン、アクリロニトリルポリマー、ナイロ ン、天然多糖類、修飾多糖類、アミラーゼ、コラーゲン、天然セルロース、修飾 セルロース、寒天およびマグネタイトからなる群より選ばれた材料からつくられ る、請求項1記載の方法。
- 5.支持体マトリックスが酸化ケイ素である、請求項4記載の方法。
- 6.細胞が神経もしくは傍神経に由来する、請求項1記載の方法。
- 7.細胞が副腎クロム親和性細胞である、請求項6記載の方法。
- 8.細胞が網膜色素上皮細胞である、請求項1記載の方法。
- 9.細胞がインビトロで培養された細胞系からのものである、請求項1記載の方 法。
- 10.培養細胞が繊維芽細胞である、請求項9記載の方法。
- 11.培養細胞がタンパク質もしくは複数のタンパクをコードする遺伝物質のト ランスフェクションにより遺伝的に修飾されており、遺伝的に修飾された該細胞 が神経伝達物質もしくは神経成長因子を生産できるようにしてある、請求項9記 載の方法。
- 12.請求項1の方法により疾患を治療できる効果的な数の細胞を被験者の脳中 に移植することからなる、被験者の神経学的疾患を治療する方法。
- 13.疾患がパーキンソン病、アルツハイマー病、ハンテントン病、てんかん、 および外傷性脳損傷からなる群より選ばれる、請求項12記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59980290A | 1990-10-19 | 1990-10-19 | |
US599,802 | 1990-10-19 | ||
PCT/US1991/007443 WO1992006702A1 (en) | 1990-10-19 | 1991-10-09 | A method for transplanting cells into the brain and therapeutic uses therefor |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003304393A Division JP3766668B2 (ja) | 1990-10-19 | 2003-08-28 | 脳中への細胞の移植のための医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06502406A true JPH06502406A (ja) | 1994-03-17 |
JP3657001B2 JP3657001B2 (ja) | 2005-06-08 |
Family
ID=24401152
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51806691A Expired - Fee Related JP3657001B2 (ja) | 1990-10-19 | 1991-10-09 | 脳中への細胞の移植方法およびそのための治療的使用 |
JP2003304393A Expired - Fee Related JP3766668B2 (ja) | 1990-10-19 | 2003-08-28 | 脳中への細胞の移植のための医薬組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003304393A Expired - Fee Related JP3766668B2 (ja) | 1990-10-19 | 2003-08-28 | 脳中への細胞の移植のための医薬組成物 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0554352B1 (ja) |
JP (2) | JP3657001B2 (ja) |
AT (1) | ATE233809T1 (ja) |
AU (1) | AU665933B2 (ja) |
CA (1) | CA2094280C (ja) |
DE (1) | DE69133205T2 (ja) |
DK (1) | DK0554352T3 (ja) |
ES (1) | ES2193132T3 (ja) |
HK (1) | HK1013802A1 (ja) |
WO (1) | WO1992006702A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022506639A (ja) * | 2018-11-04 | 2022-01-17 | フィジーン、エルエルシー | 脳卒中、慢性外傷性脳症、及び外傷性脳損傷を含む脳性低酸素症の治療 |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618531A (en) | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
WO1993014790A1 (en) * | 1992-01-23 | 1993-08-05 | New York University | A method for transplanting cells into the brain and therapeutic uses therefor |
IL109280A0 (en) * | 1993-04-15 | 1994-07-31 | Regeneron Pharma | Neurotrophins for treatment of depression |
JP3841427B2 (ja) * | 1993-04-30 | 2006-11-01 | マサチューセッツ・インスティテュート・オブ・テクノロジー | 注入可能な多糖類−細胞組成物 |
EP2025353A2 (en) * | 1993-04-30 | 2009-02-18 | Massachusetts Institute of Technology | Injectable polysaccharide-cell compositions |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5830460A (en) | 1995-03-13 | 1998-11-03 | University Of South Florida | Sertoli cells as transplantation facilitator for cell transplantation |
NZ304646A (en) * | 1995-03-13 | 1998-01-26 | Univ South Florida | Sertoli cells as neuro-recovery inducing cells for neurodegenerative disorders |
WO1996028174A1 (en) * | 1995-03-13 | 1996-09-19 | University Of South Florida | Sertoli cells as transplantation facilitator for cell transplantation |
US5855610A (en) | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
US5741685A (en) * | 1995-06-07 | 1998-04-21 | Children's Medical Center Corporation | Parenchymal cells packaged in immunoprotective tissue for implantation |
ATE258810T1 (de) * | 1995-11-09 | 2004-02-15 | Univ Massachusetts | Wiederherstellung der gewebeoberfläche mit zusammensetzungen aus hydrogel-zellen |
JP4072203B2 (ja) * | 1996-01-23 | 2008-04-09 | 株式会社エスアールエル | 痴呆症治療用細胞 |
US6210664B1 (en) * | 1996-04-08 | 2001-04-03 | New York University Medical Center | Method for gene transfer to the central nervous system |
US6660301B1 (en) | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
US6171610B1 (en) | 1998-04-24 | 2001-01-09 | University Of Massachusetts | Guided development and support of hydrogel-cell compositions |
US6027744A (en) * | 1998-04-24 | 2000-02-22 | University Of Massachusetts Medical Center | Guided development and support of hydrogel-cell compositions |
AU2001249221A1 (en) | 2000-03-20 | 2001-10-03 | Biosphere Medical, Inc. | Injectable and swellable microspheres for tissue bulking |
EP1656957B1 (en) * | 2000-03-20 | 2015-06-03 | Biosphere Medical, Inc. | Injectable microspheres for tissue construction |
EP2283880A3 (en) * | 2000-03-20 | 2014-07-09 | Biosphere Medical, Inc. | Injectable microspheres for tissue construction |
US7338657B2 (en) | 2001-03-15 | 2008-03-04 | Biosphere Medical, Inc. | Injectable microspheres for tissue construction |
US6436424B1 (en) | 2000-03-20 | 2002-08-20 | Biosphere Medical, Inc. | Injectable and swellable microspheres for dermal augmentation |
EP1627911A1 (en) | 2004-08-20 | 2006-02-22 | Schering Aktiengesellschaft | Washing apparatus |
US8382704B2 (en) | 2006-12-29 | 2013-02-26 | Medrad, Inc. | Systems and methods of delivering a dilated slurry to a patient |
CN104726394B (zh) | 2009-11-12 | 2018-12-18 | VCell治疗股份有限公司 | 类孢子细胞子群及其用途 |
EP2351779B1 (en) | 2010-01-27 | 2019-04-24 | Biosphere Medical, Inc. | Microspheres and method of making the microspheres |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
EP3955918A1 (en) | 2019-04-17 | 2022-02-23 | COMPASS Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4748121A (en) * | 1984-11-30 | 1988-05-31 | Ppg Industries, Inc. | Porous glass fibers with immobilized biochemically active material |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US4900553A (en) * | 1987-09-11 | 1990-02-13 | Case Western Reserve University | Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
US4892538A (en) * | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
ES2072434T3 (es) * | 1989-04-25 | 1995-07-16 | Childrens Medical Center | Implantes para grandes volumenes de celulas sobre matrices polimeras. |
-
1991
- 1991-10-09 ES ES91919823T patent/ES2193132T3/es not_active Expired - Lifetime
- 1991-10-09 AT AT91919823T patent/ATE233809T1/de not_active IP Right Cessation
- 1991-10-09 DE DE69133205T patent/DE69133205T2/de not_active Expired - Fee Related
- 1991-10-09 JP JP51806691A patent/JP3657001B2/ja not_active Expired - Fee Related
- 1991-10-09 EP EP91919823A patent/EP0554352B1/en not_active Expired - Lifetime
- 1991-10-09 AU AU89235/91A patent/AU665933B2/en not_active Ceased
- 1991-10-09 DK DK91919823T patent/DK0554352T3/da active
- 1991-10-09 WO PCT/US1991/007443 patent/WO1992006702A1/en active IP Right Grant
- 1991-10-09 CA CA002094280A patent/CA2094280C/en not_active Expired - Fee Related
-
1998
- 1998-12-24 HK HK98115295A patent/HK1013802A1/xx not_active IP Right Cessation
-
2003
- 2003-08-28 JP JP2003304393A patent/JP3766668B2/ja not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022506639A (ja) * | 2018-11-04 | 2022-01-17 | フィジーン、エルエルシー | 脳卒中、慢性外傷性脳症、及び外傷性脳損傷を含む脳性低酸素症の治療 |
Also Published As
Publication number | Publication date |
---|---|
EP0554352B1 (en) | 2003-03-05 |
EP0554352A4 (ja) | 1994-04-27 |
DK0554352T3 (da) | 2003-06-10 |
CA2094280C (en) | 2003-07-29 |
WO1992006702A1 (en) | 1992-04-30 |
JP3657001B2 (ja) | 2005-06-08 |
AU8923591A (en) | 1992-05-20 |
DE69133205T2 (de) | 2003-12-11 |
ATE233809T1 (de) | 2003-03-15 |
DE69133205D1 (de) | 2003-04-10 |
EP0554352A1 (en) | 1993-08-11 |
AU665933B2 (en) | 1996-01-25 |
HK1013802A1 (en) | 1999-09-10 |
CA2094280A1 (en) | 1992-04-20 |
ES2193132T3 (es) | 2003-11-01 |
JP2004041757A (ja) | 2004-02-12 |
JP3766668B2 (ja) | 2006-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06502406A (ja) | 脳中への細胞の移植方法およびそのための治療的使用 | |
US6264943B1 (en) | Method for transplanting cells into the brain and therapeutic uses therefor | |
EP1261357B1 (en) | Isolation and transplantation of retinal stem cells | |
US5202120A (en) | Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes | |
Lu et al. | Transplantation of EGF-responsive neurospheres from GFP transgenic mice into the eyes of rd mice | |
AU2001234998A1 (en) | Isolation and transplantation of retinal stem cells | |
US20060292128A1 (en) | Methods of treating schizophrenia | |
CN1192781A (zh) | 神经衍生胎儿细胞系在移植治疗中的应用 | |
JP2002500202A (ja) | 免疫優位部位の生成のための色素性網膜上皮細胞の使用 | |
AU5189896A (en) | Sertoli cells as transplantation facilitator for cell transplantation | |
de la Fuente et al. | A method for obtaining Schwann cell cultures from adult rabbit nerve based on “in vitro” pre-degeneration and neuregulin treatment | |
AU3586993A (en) | A method for transplanting cells into the brain and therapeutic uses therefor | |
EP0814819B1 (en) | Sertoli cells as transplantation facilitator for cell transplantation | |
JP2011005222A (ja) | カプセル化細胞の移植による神経疾患治療 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041102 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041220 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050308 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080318 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090318 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100318 Year of fee payment: 5 |
|
LAPS | Cancellation because of no payment of annual fees |